0000950170-23-025535.txt : 20230602 0000950170-23-025535.hdr.sgml : 20230602 20230601072603 ACCESSION NUMBER: 0000950170-23-025535 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230531 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20230601 DATE AS OF CHANGE: 20230601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marpai, Inc. CENTRAL INDEX KEY: 0001844392 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40904 FILM NUMBER: 23983000 BUSINESS ADDRESS: STREET 1: 5701 EAST HILLSBOROUGH AVENUE, SUITE 141 CITY: TAMPA STATE: FL ZIP: 33610 BUSINESS PHONE: 646-303-3483 MAIL ADDRESS: STREET 1: 5701 EAST HILLSBOROUGH AVENUE, SUITE 141 CITY: TAMPA STATE: FL ZIP: 33610 8-K 1 mrai-20230531.htm 8-K 8-K
false000184439200018443922023-05-312023-05-31

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 31, 2023

 

 

MARPAI, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40904

86-1916231

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

5701 East Hillsborough Avenue, Suite 1417

 

Tampa, Florida

 

33610

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 646 303-3483

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A Common Stock, par value $0.0001 per share

 

MRAI

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Adoption of an amendment to the 2021 Global Stock Incentive Plan

On May 31, 2022, Marpai, Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “2023 Annual Meeting”). At the 2023 Annual Meeting, the Company’s stockholders approved an amendment to the Company's 2021 Global Stock Incentive Plan (the “Plan”) to increase the number of shares authorized for issuance under the Plan by 2,000,000 from 7,803,421 to 9,803,421 (the “Plan Amendment”). The Plan Amendment was previously approved, subject to stockholder approval, by the Company’s Board of Directors (the “Board”), upon the recommendation of the Board’s Compensation Committee, on April 10, 2023.

A detailed summary of the Plan Amendment is set forth in the Company’s Definitive Proxy Statement on Schedule 14A for the 2023 Annual Meeting filed with the Securities and Exchange Commission on April 12, 2023 (the “Proxy Statement”) under the caption “Proposal 2: Incentive Plan Proposal,” which summary is incorporated herein by reference.

That detailed summary of the Plan Amendment is qualified in its entirety by reference to the full text of the Plan Amendment, a copy of which is attached as Annex A to the Company’s Proxy Statement, and is incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

The final voting results of the 2023 Annual Meeting held on May 31, 2023, are set forth below. Stockholders voted on the following proposals:

Proposal No. 1 — Election of Directors

The stockholders elected the following individuals as directors of the Company to hold office until the next annual meeting of stockholders or until their successors shall have been duly elected and qualified.

Director Name

For

Against

Abstain

Broker Non-Votes

Edmundo Gonzalez

8,947,704

36,189

9,090

5,032,174

 

Yaron Eitan

8,717,924

260,710

14,349

5,032,174

 

Damien Francis Lamendola

8,945,242

38,651

9,090

5,032,174

 

Sagiv Shiv

8,964,493

19,341

9,149

5,032,174

 

Mohsen Moazami

8,427,816

551,018

14,149

5,032,174

 

Vincent Kane

8,430,266

546,428

16,289

5,032,174

 

Coleen DiClaudio

8,965,000

11,694

162,89

5,032,174

 

 


Proposal No. 2 — Approval of the Plan Amendment.

For

Against

Abstain

Broker Non-Votes

8,587,499

399,368

6,116

5,032,174

Proposal No. 3 — Ratification of the appointment by the Audit Committee of the Board of UHY LLP, as the Company’s independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023.

For

Against

Abstain

Broker Non-Votes

14,009,396

6,814

8,947

N/A

The results reported above are final voting results.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MARPAI, INC

 

 

 

 

Date:

May 31, 2023

By:

/s/ Edmundo Gonzalez

 

 

 

Name: Edmundo Gonzalez
Title: Chief Executive Officer

 


EX-101.LAB 2 mrai-20230531_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Securities Act File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications EX-101.PRE 3 mrai-20230531_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 4 mrai-20230531.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information
May 31, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 31, 2023
Entity Registrant Name MARPAI, INC.
Entity Central Index Key 0001844392
Entity Emerging Growth Company true
Securities Act File Number 001-40904
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 86-1916231
Entity Address, Address Line One 5701 East Hillsborough Avenue, Suite 1417
Entity Address, City or Town Tampa
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33610
City Area Code 646
Local Phone Number 303-3483
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period true
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share
Trading Symbol MRAI
Security Exchange Name NASDAQ
XML 6 mrai-20230531_htm.xml IDEA: XBRL DOCUMENT 0001844392 2023-05-31 2023-05-31 false 0001844392 8-K 2023-05-31 MARPAI, INC. DE 001-40904 86-1916231 5701 East Hillsborough Avenue, Suite 1417 Tampa FL 33610 646 303-3483 false false false false Class A Common Stock, par value $0.0001 per share MRAI NASDAQ true true EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( $$[P58'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !!.\%6F/TZZN\ K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>*$YH&2;U9:6G#08K;.QF;+4UBV-C:R1]^R5>FS*V!]C1TN]/ MGT"M#D+[B,_1!XQD,=V-KNN3T&'#3D1! "1]0J=2.27ZJ7GPT2F:GO$(0>D/ M=42HJVH-#DD910IF8!$6(I.MT4)'5.3C!6_T@@^?L M&,YCU\(-,,,(HTO?!30+,5?_Q.8.L$MR3'9)#<-0#DW.33MP>'MZ?,GK%K9/ MI'J-TZ]D!9T#;MAU\FOSL-WOF*RKNBFJ=5'Q/>>B7HG5_?OL^L/O)NR\L0?[ MCXVO@K*%7W&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" !!.\%6FXQSR8<$ !&$0 & 'AL+W=OFT,TFP;(>0%)AQ2-)C+LEQ(>W-M-,/PA:@B6WY)!G" MO^_*@$U3L^8+6$;[^M%JM;NFOY;J32\Y-^0]33(]<);&Y#>=CHZ6/&7Z0N8\ M@U_F4J7,P% M.CI7G,6E49IT/-?M=E(F,F?8+^]-U+ O"Y.(C$\4T46:,K6Y MY8E<#QSJ[&^\B,72V!N=83]G"S[EYH]\HF#4J51BD?),"YD1Q><#)Z0WM]ZE M-2AG_"GX6A]<$[N4F91O=C".!XYKB7C"(V,E&'RM^(@GB54"CA\[4:=ZIC4\ MO-ZK/Y2+A\7,F.8CF7P7L5D.G)Y#8CYG16)>Y/HSWRVH!(QDHLM/LM[.#0*' M1(4V,MT9 T$JLNTW>]\YXL#@TCUBX.T,O))[^Z"2\HX9-NPKN2;*S@8U>U$N MM;0&.)'979D:!;\*L#/#.QD5X&1#PBPF]YD19D/&V7:WP6O]CH&'V*F=:"=X MNQ7TC@@^L0WQZ1GQ7,__KW4'T"H^K^+S2CG_B-Q(KK@B?X9JQ9WASS_1KOL;PN=7?#ZF7OOO=9/S)CC*5CW*5<+D2W([V!OEF0DTYQEC7"X MGE$%%E[7%=8U*C/E4:&$$5R3,()8%PDGST4ZXZH)"=<"=YT'[K4;(%S4K9.H M>XK#QEDD52Y5F3K/R-1 [!.IP'$%;##LLXP;8ZY%_>X>@SS(]/04R%?V3L8Q M1)R8BZ@D19S8(MGKGM-KVO5\BA'6N9ZBJ7I/&,8Q)&I]MK\@CS"/?,V:?8=+ M7EZYE-PS;80NHBP'%T_G'!8SL" +@ M5:Z;2RDN]\K@P&%@=8&@>(;_"%:%YD3)EZC^B3:0V MD O_$OGQ\X(K^GZ7NAA;734HGN[+_0NAVSV.@@MT@RX&4M<)BJ?W1QF!3R9+ MF6$IKT7$=_US/^AA]936)8+B.?T[9&+#,UL4TB+;91+=2(4+M34?M"X/M*4^ MR$1$4!^@8CU!>"O!DD8>7*6-QZNK@H?G[8GBYQ&XA\/YVO:(T*9!-_MU/F_> MOQ:]5K*Z%'AXWOX?V5CK LA: 7'95L"#KO^D2G#_3EZA6].B+%/;KK*1"U=K MZ3^\.K][+0E9&.@YY)Q0[Y?9KV37D#1V1"U*HX1!80O+XP-+FQH9O9V1G"FR M8DG!R2?WPK9T)(?MT$NF4/ZZ#'AXR@9GQO9X3#?I3#8>CA:!IY=PC)'46=_# M<_3>=;#%T9)E"WZT(6\1>@ZG=^&W)J;.P5NQ_8?AB=EN5I.$ST')O;@"8;5] M:=\.C,S+%^69-/#:75XN.8,#82? [W,IS7Y@W[VKOTZ&_P)02P,$% @ M03O!5I^@&_"Q @ X@P T !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@ M;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W M)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP M4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W M8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM M5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLY MS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5B M'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0)P M:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%PZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X M3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3 MB.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0ERHY_U=3 M_ 102P,$% @ 03O!5I>*NQS $P( L !?3T\$MP> M:4#M.*2VBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5; M&GC3Y?YVX$G1H2)8%II%R=.B':5_'36TGH MX-R#8._AE8P=S8\?=_<#4$L#!!0 ( $$[P58D'INBK0 /@! : M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q= M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*'3^ 5!+ P04 " !!.\%699!YDAD! #/ P M$P %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M= M< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4' M3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!- MFI6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXP MC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T, M:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0 ( M $$[P58'04UB@0 +$ 0 " 0 !D;V-0&UL4$L! A0#% @ 03O!5IC].NKO *P( !$ M ( !KP &1O8U!R;W!S+V-O&UL4$L! A0#% @ 03O!5IE&PO=V]R:W-H965T&UL4$L! A0#% @ 03O!5I^@&_"Q M @ X@P T ( !RPP 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! A0#% @ 03O!5B0>FZ*M M^ $ !H ( !_1$ 'AL+U]R96QS+W=O9(9 0 SP, !, ( ! MXA( %M#;VYT96YT7U1Y<&5S72YX;6Q02P4& D "0 ^ @ +!0 end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports mrai-20230531.htm mrai-20230531.xsd mrai-20230531_lab.xml mrai-20230531_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mrai-20230531.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "mrai-20230531.htm" ] }, "labelLink": { "local": [ "mrai-20230531_lab.xml" ] }, "presentationLink": { "local": [ "mrai-20230531_pre.xml" ] }, "schema": { "local": [ "mrai-20230531.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "mrai", "nsuri": "http://www.marpaihealth.com/20230531", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "mrai-20230531.htm", "contextRef": "C_1f972092-acc4-47db-abf1-c69d678a8431", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "mrai-20230531.htm", "contextRef": "C_1f972092-acc4-47db-abf1-c69d678a8431", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.marpaihealth.com/20230531/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0000950170-23-025535-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-025535-xbrl.zip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ˑ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end